NCT01055691View on ClinicalTrials.gov

A Study Comparing the Amount of Metformin and After Taking a Combination Tablet vs. Separate Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Healthy Volunteers
Interventions
DRUG

Dapagliflozin/Metformin

Fixed dose combination dapagliflozin/metformin IR tablet 2.5 mg/850 mg Oral Single dose

DRUG

Dapagliflozin

dapagliflozin tablet 2.5 mg Oral Single dose

DRUG

Metformin

metformin IR tablet 850 mg Oral Single dose

DRUG

Dapagliflozin/Metformin

Fixed dose combination dapagliflozin/metformin IR tablet 5 mg/1000 mg Oral Single dose

DRUG

Dapagliflozin

dapagliflozin tablet 5 mg Oral Single dose

DRUG

Metformin

metformin IR tablet 1000 mg Oral Single dose

Trial Locations (1)

Unknown

Research Site, Berlin

Sponsors

Lead Sponsor

AstraZeneca

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

AstraZeneca

INDUSTRY